Armstrong Mac sold $472K of PLMR (indirect holdings)

Armstrong Mac (CEO and Chairman) sold 3,500 indirectly-held shares of Palomar Holdings, Inc. (PLMR) at an average of $134.98 ($134.60–$135.57, $0.47M total) across 2 trades on 2026-09-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Armstrong Mac
Published Sep 22, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 8:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PLMR
Neutral
medium confidence
Mentioned
$PLMR
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLMRNeutralLow
01

Why it matters

The disclosed sale reduces the CEO's ownership and may influence investor perception, but the amount is relatively small for a mid‑cap company.

02

Market read

Primary insider sale; modest size; likely limited price impact.

03

What to watch

The 10b5‑1 plan pre‑arranges sales, reducing the informational value of the transaction.

Relevance 3/10Novelty 5/10Timing: filing date 2026‑09‑22 (after‑hours)

Background

Form 4 filings disclose insider transactions; this is the first public report of the CEO's recent sale.

Company-level read

Ticker impact

$PLMRNeutralMedium confidence
Context

CEO Armstrong Mac sold 3,500 shares for $472K via a 10b5‑1 plan, reducing his stake to 318,888 shares.

Expected impact

Potential short‑term downward pressure on PLMR as the market digests the insider sell.

Evidence & confidence

The sale is modest in absolute terms but involves the top executive; markets often react negatively to insider sells, especially when executed through a pre‑arranged plan.

Market effects

Minimal impact on the broader biotech/health‑care sector.

Limited to U.S. investors tracking PLMR.

Low

Counterpoint

The sale may be purely portfolio‑rebalancing; the CEO could still be bullish on long‑term prospects.

Key entities

  • Armstrong Mac

    CEO and Chairman of Palomar Holdings, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PLMRHighAI 8/10

Palomar Holdings, Inc. (PLMR): Investor Presentation November 2026

Palomar Holdings, Inc. (PLMR) filed an SEC Form 8-K — Regulation FD Disclosure. Investor Presentation November 2026 Disclaimer This presentation contains forward-looking statements about Palomar Holdings, Inc. (the “Company”). These statements involve known and unknown risks that relate to the Company’s future events or future financial performance and the a

$PLMRHigh

Keefe Bruyette raises Palomar Holdings stock price target on earnings beat

Keefe Bruyette & Woods raised its price target for Palomar Holdings (PLMR) to $172 from $161, citing strong Q3 2026 earnings and updated financial estimates. The firm expects lower core loss ratios and faster net investment income growth. PLMR reported adjusted EPS of $3.01, beating estimates, and raised its full-year adjusted net income guidance. Truist Securities also increased its price target to $175.

$PLMRMed

Palomar Q3 Earnings Call Highlights

Palomar (PLMR) reported Q3 earnings, with CFO Chris Uchida noting $425M in crop premiums and confidence in reaching a $500M intermediate goal. CEO Armstrong highlighted growth in earthquake, inland marine, and property premiums, despite commercial rate pressure. The company's adjusted combined ratio was 76.3%, up from 74.8% YoY, with a total loss ratio of 41.5%. Palomar expects continued growth and capital returns, including dividends and stock repurchases.

$PLMRHighAI 8/10

Palomar Holdings Inc (PLMR) (Q3 2026) Earnings Call Highlights: Record Premium, 16th

Palomar Holdings Inc (PLMR) reported record Q3 2026 results with gross written premium up 28% YoY and adjusted net income of $81.3M. Adjusted EPS grew 50%, and the combined ratio was 76%. All product categories grew, with crop and surety leading. Guidance was raised to $280M-$285M for full-year adjusted net income. Challenges include decelerated casualty growth and catastrophe losses.

$PLMRMed

Truist raises Palomar Holdings stock price target on earnings growth

Truist Securities raised its price target on Palomar Holdings (PLMR) to $175 from $168, citing earnings growth and strong fundamentals. The stock trades at $153.07 with a market cap of $4.04B. Truist also increased its 2026 and 2027 EPS estimates, noting revenue growth of 58% and a 23% return on equity. Palomar reported Q3 2026 earnings of $3.01 per share, beating estimates.